# Ajovy (fremanezumab-vfrm) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/fremanezumab-vfrm

> The FDA approved Ajovy (fremanezumab-vfrm), sponsored by TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), on September 14, 2018.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | Ajovy (fremanezumab-vfrm) |
| Codes |  |
| Sponsor | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) https://sec-api.dev/companies/teva/catalysts |
| Indications |  |
| Modality | biologic |
| FDA designations | priority review |

## Timeline

### September 14, 2018: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "BLA761089 ORIG-1 (Type 1 - New Molecular Entity): submission_status AP, submission_status_date 20180914, review_priority PRIORITY; sponsor_name TEVA PHARMS USA; product AJOVY (FREMANEZUMAB-VFRM)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22BLA761089%22

### January 27, 2020: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "BLA761089 SUPPL-2 (Efficacy): submission_status AP, submission_status_date 20200127, review_priority STANDARD; sponsor_name TEVA PHARMS USA; product AJOVY (FREMANEZUMAB-VFRM)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22BLA761089%22

### August 5, 2025: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "BLA761089 SUPPL-31 (Efficacy): submission_status AP, submission_status_date 20250805, review_priority PRIORITY; sponsor_name TEVA PHARMS USA; product AJOVY (FREMANEZUMAB-VFRM)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22BLA761089%22

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/fremanezumab-vfrm.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Ajovy (fremanezumab-vfrm) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/fremanezumab-vfrm

```bibtex
@misc{secapidev_pdufa_fremanezumab_vfrm_20261116,
  title        = {Ajovy (fremanezumab-vfrm) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/fremanezumab-vfrm}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_fremanezumab_vfrm_20261116","title":"Ajovy (fremanezumab-vfrm) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/fremanezumab-vfrm","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
